Article
Clinical validation of the PCR-reverse dot blot human papillomavirus genotyping test in cervical lesions from Chinese women in the Fujian province: a hospital-based population study.
Journal of gynecologic oncology - 1 Sept 2017
Sun Pengming, Song Yiyi, Ruan Guanyu, Mao Xiaodan, Kang Yafang, Dong Binhua, Lin Fen
Abstract excerpt
OBJECTIVE: To determine the clinical significance of the polymerase chain reaction (PCR)-reverse dot blot (RDB) human papillomavirus (HPV) genotyping assay in cervical cancer screening. METHODS: A total of 10,442 women attending the Fujian Provincial Maternity and Children's Health Hospital were evaluated using the liquid-based cytology (thinprep cytologic test [TCT]) and the PCR-RDB HPV test. Women with HPV...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
